All In MedTech

Device Trial Radar · NCT01787227

A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel

A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection

Last checked: Nov 20, 2026Latest source record: Mar 3, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Sponsor

Lead sponsor
Luminex Molecular DiagnosticsNot on our public-company list
Sponsor type
Industry
First posted
Feb 8, 2013

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

xTAG RPP assay is a PCR-based assay to detect the presence or absence of viral and bacterial DNA / RNA in clinical specimens (nasopharyngeal swabs). The objective of this study is to establish diagnostic accuracy of the xTAG RPP.

Conditions

  • Respiratory Tract Infection
  • Bronchitis
  • Bronchiolitis
  • Pneumonia

Interventions

  • xTAG RPPDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Diagnostic accuracy will be expressed in terms of clinical sensitivity and specificity for each claimed target.Time frame: Within the first year after sample extraction

Locations

4 sites in 2 countries. Site status is shown where the registry gives one.

  • St. Louis Children's Hospital

    St Louis, Missouri

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.